InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: None

Friday, 07/17/2020 10:00:05 AM

Friday, July 17, 2020 10:00:05 AM

Post# of 232963
The debate here has been about the probability of the clinical results being meaningful enough to place the FDA behind the eight ball.

The Bullish crowd has been handicapped as an overwhelming favorite as evidence by the current upward momentum of the SP.

All Covid data related to Leronlimab up to this point is more than anecdotal it’s statistically relevant if you believe the telegraphing by Dr. Patterson and Lalezari. Now it’s time for the rubber to hit the road and prove it.

We, the investors, the purchasers and sellers of CYDY shares are the odds makers. The odds fluctuate on a daily basis. Will the SP push higher as the timeline to the M2M read out nears or will it contract? Also factored in is the more pivotal Severe Trial for 390 patients following the M2M read out. If there is a high level of confidence from the market in statistically relevant results the SP will move higher and vice versa.

If your a Long that has built a position in the depression days of CYDY - sub .50 you’ve got a free front row seat to the Covid Super Bowl. If you started buying within the Covid run up you represent the majority of a growing fan base that wants a ticket and is willing to pay.

What will the betting line be just prior to kick off? That’s what the buzz is all about.

Here’s the kicker, nobody knows exactly what day the game will be played.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News